Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mucocutaneous Lymph Node Syndrome | 26 | 2024 | 546 | 7.360 |
Why?
|
Systemic Inflammatory Response Syndrome | 26 | 2024 | 611 | 4.350 |
Why?
|
Immunoglobulins, Intravenous | 16 | 2023 | 658 | 2.920 |
Why?
|
Coronary Aneurysm | 8 | 2023 | 237 | 2.380 |
Why?
|
Lupus Erythematosus, Systemic | 10 | 2023 | 2103 | 1.870 |
Why?
|
Rheumatology | 8 | 2023 | 576 | 1.420 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 5 | 2023 | 297 | 1.190 |
Why?
|
Glucocorticoids | 10 | 2023 | 2108 | 1.110 |
Why?
|
Macrophage Activation Syndrome | 5 | 2023 | 111 | 0.910 |
Why?
|
Immunomodulation | 4 | 2023 | 541 | 0.790 |
Why?
|
Child | 59 | 2024 | 77679 | 0.750 |
Why?
|
Insurance | 1 | 2022 | 111 | 0.750 |
Why?
|
Antirheumatic Agents | 6 | 2022 | 1339 | 0.730 |
Why?
|
Anti-Inflammatory Agents | 4 | 2014 | 1789 | 0.630 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3712 | 0.630 |
Why?
|
Delayed Diagnosis | 2 | 2021 | 441 | 0.630 |
Why?
|
Risk Adjustment | 1 | 2021 | 594 | 0.590 |
Why?
|
Critical Pathways | 1 | 2021 | 476 | 0.590 |
Why?
|
Connective Tissue Diseases | 3 | 2023 | 264 | 0.540 |
Why?
|
Child, Preschool | 30 | 2023 | 40992 | 0.510 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2236 | 0.510 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1854 | 0.500 |
Why?
|
Fever | 4 | 2023 | 1614 | 0.500 |
Why?
|
Hyperglycemia | 1 | 2022 | 1372 | 0.460 |
Why?
|
Vaccines | 1 | 2022 | 822 | 0.450 |
Why?
|
Injections, Intra-Articular | 1 | 2014 | 278 | 0.440 |
Why?
|
Pneumonia, Viral | 4 | 2022 | 3239 | 0.400 |
Why?
|
Infant | 21 | 2022 | 35129 | 0.400 |
Why?
|
Musculoskeletal Diseases | 2 | 2023 | 581 | 0.400 |
Why?
|
Prednisolone | 1 | 2012 | 334 | 0.380 |
Why?
|
Patient Education as Topic | 1 | 2021 | 2277 | 0.380 |
Why?
|
Echocardiography | 3 | 2019 | 5103 | 0.380 |
Why?
|
Adolescent | 31 | 2023 | 85759 | 0.380 |
Why?
|
Humans | 88 | 2024 | 744220 | 0.380 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2576 | 0.370 |
Why?
|
Rheumatic Diseases | 3 | 2023 | 593 | 0.360 |
Why?
|
Coronary Vessel Anomalies | 2 | 2020 | 314 | 0.360 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2021 | 2072 | 0.360 |
Why?
|
Decision Support Techniques | 2 | 2017 | 1955 | 0.360 |
Why?
|
Pandemics | 5 | 2024 | 8387 | 0.350 |
Why?
|
Kidney Failure, Chronic | 1 | 2022 | 2538 | 0.350 |
Why?
|
Pediatrics | 3 | 2021 | 3469 | 0.340 |
Why?
|
Retrospective Studies | 23 | 2024 | 77426 | 0.330 |
Why?
|
Immunoglobulins | 1 | 2012 | 881 | 0.320 |
Why?
|
Interferon Type I | 2 | 2023 | 542 | 0.310 |
Why?
|
Coronavirus Infections | 3 | 2020 | 3132 | 0.310 |
Why?
|
Coronary Vessels | 2 | 2017 | 3107 | 0.310 |
Why?
|
Health Status Disparities | 2 | 2019 | 1797 | 0.280 |
Why?
|
Young Adult | 13 | 2023 | 56436 | 0.270 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4419 | 0.260 |
Why?
|
Female | 43 | 2023 | 380197 | 0.250 |
Why?
|
Male | 40 | 2022 | 350027 | 0.250 |
Why?
|
Mevalonate Kinase Deficiency | 1 | 2023 | 19 | 0.230 |
Why?
|
Sweet Syndrome | 1 | 2023 | 47 | 0.230 |
Why?
|
Chest Pain | 1 | 2010 | 1114 | 0.230 |
Why?
|
Drug Therapy, Combination | 5 | 2021 | 6485 | 0.220 |
Why?
|
Meningitis, Aseptic | 1 | 2023 | 59 | 0.220 |
Why?
|
Antibodies, Monoclonal | 2 | 2010 | 9275 | 0.220 |
Why?
|
Diagnosis, Differential | 9 | 2021 | 12961 | 0.220 |
Why?
|
Hospitalization | 5 | 2021 | 10262 | 0.210 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 236 | 0.210 |
Why?
|
Immunosuppressive Agents | 5 | 2023 | 4151 | 0.210 |
Why?
|
Anxiety | 1 | 2016 | 4297 | 0.200 |
Why?
|
Interleukin-18 | 2 | 2020 | 249 | 0.200 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7659 | 0.200 |
Why?
|
C-Reactive Protein | 7 | 2023 | 3778 | 0.190 |
Why?
|
Facial Hemiatrophy | 1 | 2020 | 22 | 0.190 |
Why?
|
Child, Hospitalized | 1 | 2022 | 174 | 0.190 |
Why?
|
Agammaglobulinemia | 1 | 2022 | 167 | 0.190 |
Why?
|
Paris | 1 | 2020 | 42 | 0.190 |
Why?
|
Primary Ovarian Insufficiency | 1 | 2021 | 115 | 0.180 |
Why?
|
Pulmonary Alveolar Proteinosis | 1 | 2020 | 42 | 0.180 |
Why?
|
Panniculitis | 1 | 2020 | 44 | 0.180 |
Why?
|
Enteritis | 1 | 2021 | 165 | 0.180 |
Why?
|
Logistic Models | 3 | 2021 | 13409 | 0.180 |
Why?
|
Boston | 4 | 2023 | 9311 | 0.180 |
Why?
|
Synovial Fluid | 1 | 2021 | 394 | 0.170 |
Why?
|
Stroke Volume | 5 | 2023 | 5008 | 0.170 |
Why?
|
Erythema | 1 | 2020 | 257 | 0.170 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7784 | 0.170 |
Why?
|
Length of Stay | 4 | 2020 | 6308 | 0.170 |
Why?
|
Atrioventricular Block | 1 | 2020 | 120 | 0.170 |
Why?
|
France | 1 | 2020 | 517 | 0.170 |
Why?
|
Thrombophilia | 1 | 2021 | 305 | 0.160 |
Why?
|
Shock | 1 | 2021 | 318 | 0.160 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 1 | 2022 | 260 | 0.160 |
Why?
|
Eosinophilia | 1 | 2023 | 542 | 0.160 |
Why?
|
Lung Diseases | 2 | 2023 | 1885 | 0.160 |
Why?
|
Prednisone | 1 | 2023 | 1575 | 0.160 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.160 |
Why?
|
Cell Polarity | 1 | 2021 | 645 | 0.160 |
Why?
|
Ventricular Function, Left | 4 | 2023 | 3669 | 0.160 |
Why?
|
Severity of Illness Index | 4 | 2023 | 15538 | 0.160 |
Why?
|
Opportunistic Infections | 1 | 2021 | 389 | 0.150 |
Why?
|
Age of Onset | 3 | 2023 | 3270 | 0.150 |
Why?
|
Adenosine Deaminase | 1 | 2019 | 241 | 0.150 |
Why?
|
Treatment Failure | 1 | 2023 | 2619 | 0.150 |
Why?
|
Syndrome | 2 | 2021 | 3250 | 0.140 |
Why?
|
Depression | 1 | 2016 | 7767 | 0.140 |
Why?
|
Aftercare | 1 | 2022 | 866 | 0.140 |
Why?
|
Focus Groups | 1 | 2021 | 1321 | 0.140 |
Why?
|
Bacterial Infections | 2 | 2021 | 1401 | 0.130 |
Why?
|
Patient Transfer | 1 | 2022 | 761 | 0.130 |
Why?
|
Blood Coagulation | 1 | 2021 | 1127 | 0.130 |
Why?
|
Treatment Outcome | 8 | 2023 | 63119 | 0.130 |
Why?
|
California | 1 | 2019 | 1402 | 0.130 |
Why?
|
Interleukin-10 | 1 | 2020 | 1200 | 0.130 |
Why?
|
Risk Assessment | 4 | 2021 | 23337 | 0.130 |
Why?
|
Risk Factors | 11 | 2023 | 72280 | 0.130 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 945 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1223 | 0.120 |
Why?
|
Propensity Score | 1 | 2021 | 1781 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1782 | 0.120 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15070 | 0.120 |
Why?
|
Biological Products | 1 | 2023 | 860 | 0.120 |
Why?
|
Prognosis | 3 | 2021 | 29050 | 0.120 |
Why?
|
Infertility | 1 | 2021 | 655 | 0.120 |
Why?
|
Psoriasis | 1 | 2022 | 898 | 0.120 |
Why?
|
North America | 1 | 2017 | 1250 | 0.120 |
Why?
|
Triamcinolone Acetonide | 1 | 2014 | 101 | 0.120 |
Why?
|
Japan | 1 | 2018 | 1361 | 0.120 |
Why?
|
Th17 Cells | 1 | 2020 | 766 | 0.110 |
Why?
|
Singapore | 1 | 2014 | 295 | 0.110 |
Why?
|
Age Factors | 3 | 2021 | 18367 | 0.110 |
Why?
|
Counseling | 1 | 2021 | 1523 | 0.110 |
Why?
|
T-Lymphocytes, Regulatory | 3 | 2023 | 2988 | 0.110 |
Why?
|
Pleurisy | 1 | 2013 | 53 | 0.110 |
Why?
|
United States | 11 | 2023 | 69867 | 0.110 |
Why?
|
Headache | 1 | 2020 | 1226 | 0.110 |
Why?
|
Patient Discharge | 2 | 2022 | 3313 | 0.110 |
Why?
|
Hospitals, Pediatric | 2 | 2013 | 1766 | 0.110 |
Why?
|
Evidence-Based Medicine | 3 | 2022 | 3611 | 0.110 |
Why?
|
Qualitative Research | 1 | 2021 | 2682 | 0.110 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.110 |
Why?
|
Immunologic Factors | 2 | 2021 | 1582 | 0.110 |
Why?
|
Weight Gain | 1 | 2022 | 2292 | 0.110 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2019 | 1676 | 0.100 |
Why?
|
Laryngeal Diseases | 1 | 2015 | 241 | 0.100 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 6489 | 0.100 |
Why?
|
Registries | 3 | 2023 | 8090 | 0.100 |
Why?
|
Massachusetts | 2 | 2021 | 8663 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2021 | 8628 | 0.100 |
Why?
|
Hepatomegaly | 1 | 2010 | 85 | 0.100 |
Why?
|
Interleukin-6 | 1 | 2020 | 3201 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 1 | 2020 | 1162 | 0.090 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 722 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 2021 | 1623 | 0.090 |
Why?
|
Larynx | 1 | 2015 | 494 | 0.090 |
Why?
|
Prospective Studies | 5 | 2023 | 53280 | 0.090 |
Why?
|
Social Class | 1 | 2019 | 1999 | 0.090 |
Why?
|
Inflammation | 5 | 2023 | 10634 | 0.090 |
Why?
|
Aspirin | 2 | 2021 | 3282 | 0.090 |
Why?
|
Sarcoidosis | 1 | 2015 | 505 | 0.090 |
Why?
|
Disease Progression | 3 | 2023 | 13280 | 0.090 |
Why?
|
Ambulatory Care | 1 | 2021 | 2708 | 0.090 |
Why?
|
Medication Adherence | 1 | 2021 | 2062 | 0.090 |
Why?
|
Pilot Projects | 1 | 2022 | 8321 | 0.090 |
Why?
|
Antibodies, Viral | 1 | 2020 | 3176 | 0.090 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 520 | 0.080 |
Why?
|
Retreatment | 1 | 2010 | 610 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.080 |
Why?
|
Vaccination | 1 | 2021 | 3278 | 0.080 |
Why?
|
Cohort Studies | 3 | 2023 | 40559 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2136 | 0.080 |
Why?
|
Heart | 1 | 2021 | 4465 | 0.080 |
Why?
|
Delphi Technique | 2 | 2021 | 778 | 0.080 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2279 | 0.080 |
Why?
|
Case-Control Studies | 5 | 2023 | 21752 | 0.070 |
Why?
|
Heart Diseases | 1 | 2020 | 2790 | 0.070 |
Why?
|
T-Lymphocytes | 2 | 2022 | 10182 | 0.070 |
Why?
|
Adult | 9 | 2023 | 214035 | 0.070 |
Why?
|
Stress, Psychological | 1 | 2021 | 4245 | 0.070 |
Why?
|
Quality Improvement | 1 | 2021 | 3746 | 0.070 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4559 | 0.070 |
Why?
|
Blood Sedimentation | 2 | 2019 | 231 | 0.060 |
Why?
|
Dyspnea | 1 | 2013 | 1303 | 0.060 |
Why?
|
Physical Examination | 1 | 2010 | 1238 | 0.060 |
Why?
|
Infant, Newborn | 4 | 2023 | 25618 | 0.060 |
Why?
|
Critical Care | 3 | 2021 | 2644 | 0.060 |
Why?
|
Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 9960 | 0.050 |
Why?
|
Software | 1 | 2016 | 4442 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 645 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 12805 | 0.050 |
Why?
|
Crowding | 1 | 2023 | 145 | 0.050 |
Why?
|
Diagnostic Errors | 2 | 2021 | 1255 | 0.050 |
Why?
|
Running | 1 | 2006 | 479 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2019 | 19907 | 0.050 |
Why?
|
Pain Measurement | 1 | 2010 | 3419 | 0.050 |
Why?
|
Lymphadenitis | 1 | 2021 | 98 | 0.050 |
Why?
|
Skin | 1 | 2014 | 4363 | 0.050 |
Why?
|
Subcutaneous Tissue | 1 | 2020 | 135 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39045 | 0.050 |
Why?
|
Conjunctivitis | 1 | 2021 | 158 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12244 | 0.040 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 314 | 0.040 |
Why?
|
Facial Muscles | 1 | 2020 | 157 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2013 | 5316 | 0.040 |
Why?
|
Thrombelastography | 1 | 2021 | 163 | 0.040 |
Why?
|
Discriminant Analysis | 1 | 2020 | 235 | 0.040 |
Why?
|
Receptor, Notch1 | 1 | 2023 | 502 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 132 | 0.040 |
Why?
|
Patient Readmission | 1 | 2013 | 3114 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17449 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13885 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2023 | 1263 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2021 | 793 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4477 | 0.040 |
Why?
|
Platelet Count | 1 | 2021 | 781 | 0.040 |
Why?
|
Databases, Factual | 1 | 2013 | 7730 | 0.040 |
Why?
|
Mouth Mucosa | 1 | 2021 | 434 | 0.040 |
Why?
|
Family Characteristics | 1 | 2023 | 1000 | 0.040 |
Why?
|
Interleukin-17 | 1 | 2023 | 900 | 0.040 |
Why?
|
Bacteriophages | 1 | 2020 | 358 | 0.040 |
Why?
|
Cytokines | 2 | 2023 | 7326 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2021 | 1584 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 35423 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2023 | 986 | 0.040 |
Why?
|
Dermatomyositis | 1 | 2019 | 224 | 0.040 |
Why?
|
Ferritins | 1 | 2019 | 590 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2021 | 1880 | 0.040 |
Why?
|
Advisory Committees | 1 | 2021 | 774 | 0.040 |
Why?
|
Th1 Cells | 1 | 2021 | 1057 | 0.030 |
Why?
|
Anticoagulants | 2 | 2021 | 4599 | 0.030 |
Why?
|
History, 21st Century | 1 | 2022 | 1534 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 29784 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2461 | 0.030 |
Why?
|
Methotrexate | 1 | 2022 | 1720 | 0.030 |
Why?
|
Hypotension | 1 | 2021 | 880 | 0.030 |
Why?
|
Virus Diseases | 1 | 2021 | 711 | 0.030 |
Why?
|
Urinary Tract Infections | 1 | 2021 | 788 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2021 | 1062 | 0.030 |
Why?
|
Face | 1 | 2020 | 994 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14726 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2038 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2021 | 979 | 0.030 |
Why?
|
Lung | 1 | 2013 | 9852 | 0.030 |
Why?
|
Biopsy | 2 | 2016 | 6757 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2013 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1477 | 0.030 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2958 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2022 | 1901 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7148 | 0.020 |
Why?
|
Regression Analysis | 1 | 2021 | 6461 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Blood Platelets | 1 | 2021 | 2508 | 0.020 |
Why?
|
Biomedical Research | 1 | 2006 | 3311 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3637 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2016 | 706 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2023 | 4665 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9849 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2050 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1126 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
Joints | 1 | 2011 | 326 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 213367 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5953 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3717 | 0.020 |
Why?
|
Aged | 1 | 2021 | 163253 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4385 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1618 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 2987 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 3068 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4289 | 0.020 |
Why?
|
Research Design | 1 | 2023 | 5987 | 0.020 |
Why?
|
Internship and Residency | 1 | 2006 | 5787 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20945 | 0.020 |
Why?
|
International Cooperation | 1 | 2011 | 1421 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25043 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 3508 | 0.010 |
Why?
|
Radiography | 1 | 2013 | 7022 | 0.010 |
Why?
|